11:07 AM EDT, 09/10/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts edged lower late Wednesday morning, declining 0.1% to 1,530.89 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and semiconductor company Sequans Communications ( SQNS ) , which rose 6.1% and 6% respectively. They were followed by biotech firm Evaxion ( EVAX ) and financial services company ING (ING), which were up 5.6% and 2.9% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biopharmaceutical company Genfit ( GNFT ) , which dropped 16% and 4.8% respectively. They were followed by software firm SAP (SAP) and biotech firm BioNTech (BNTX), which fell 3.1% and 1.4% respectively.

From the UK and Ireland, the gainers were led by biotech company Trinity Biotech ( TRIB ) and insurance provider Prudential (PUK), which advanced 4.5% and 3.4% respectively. They were followed by oil and gas company BP (BP) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which increased 1% and 0.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Mereo BioPharma ( MREO ) , which lost 7.3% and 1.9% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and telecommunications operator Vodafone ( VOD ) , which were down 1.4% and 1.2% respectively.